Ling Zeng

General Counsel, Dicerna Pharmaceuticals (United States).

Companies

Omega Therapeutics, Inc.Officer Apr 1, 2022 to Feb 9, 2024¹
Dicerna Pharmaceuticals (United States)General counsel Sep 16, 2020 to Dec 29, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dicerna Pharmaceuticals (United States)0 shares³Dec 28, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 28, 2021U 5,032 shares at $38.25 of Dicerna Pharmaceuticals (United States)³
Dec 15, 2021Shares withheld for tax 752 shares at $38.05 of Dicerna Pharmaceuticals (United States)⁴
Dec 15, 2021Exercised options 2,562 shares of Dicerna Pharmaceuticals (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROmega Therapeutics, Inc., Officer
2
SEC EDGARDicerna Pharmaceuticals (United States), General counsel
3
SEC EDGARDicerna Pharmaceuticals (United States) shares after the filing of Dec 28, 2021
4
SEC EDGARForm 4 filed Dec 17, 2021